[ad_1] Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to…
Cancer Drugs
-
-
STOCK MARKET
Novartis to bolster its oncology portfolio with acquisition of MorphoSys
by userby user[ad_1] Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys…
-
[ad_1] Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities…
-
STOCK MARKET
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
by userby user[ad_1] French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development…
-
STOCK MARKET
Panbela Therapeutics’ stock soars on positive FDA news on child cancer treatment
by userby user[ad_1] Shares of Panbela Therapeutics Inc. skyrocketed again Tuesday, following positive news from the U.S.…
-
[ad_1] Moderna Inc.’s stock soared 14% early Thursday after the biotech company and partner Merck…
-
STOCK MARKET
SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors
by userby user[ad_1] SpringWorks Therapeutics Inc. shares SWTX were on track for a record percentage gain on…
-
[ad_1] Shares of Curis Inc. CRIS, +36.55% gained nearly 6% premarket on Friday after Truist…
-
[ad_1] Wuxi XDC Cayman’s shares rose in their trading debut in Hong Kong as investors…
-
[ad_1] A unit of Chinese contract drugmaker Wuxi Biologics set its initial public offering price…